First human senescence atlas maps aging cells in detail
Which cells in the human body ‘stall out’ as we age, and exactly where? For the first time, researchers have mapped this systematically.
Cells that stop dividing but refuse to die are often called ‘zombie cells’. The scientific term is senescent cells. They accumulate in organs as we get older and secrete substances that trigger inflammation and damage surrounding healthy tissue. This process contributes to diseases such as arthritis, cancer, and Alzheimer’s.
Until now, little was known about exactly where these cells reside or how they differ across tissue types. The NIH Cellular Senescence Network (SenNet) has now changed that. Researchers mapped senescent cells at single-cell resolution using single-cell analysis and spatial transcriptomics, techniques that reveal which genes are active in each individual cell and precisely where in the tissue those cells sit.
More diversity than expected
A key finding is that senescence is not a uniform state. Aged cells differ substantially depending on cell type and tissue context. The atlas identifies multiple clearly distinct subtypes. That has direct implications for how future therapies should be designed.
From a longevity perspective, this matters because earlier animal studies showed that removing roughly a third of senescent cells produces significant health benefits in aged mice. A human tissue atlas is a step toward similar approaches in people. The researchers emphasise, however, that these findings are preliminary, the atlas is a first inventory, not proof of clinical success.
Senolytics still undertested in humans
Drugs that selectively clear senescent cells, known as senolytics, already exist. The combination of dasatinib and quercetin, for instance, improves multiple age-related conditions in mice. In humans, clinical trials have so far been small and limited in scope. The new atlas may help identify which cell types and tissues deserve priority in future research.